140 related articles for article (PubMed ID: 26722392)
1. Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway.
Hao W; Wang S; Zhou Z
Int J Clin Exp Pathol; 2015; 8(10):12075-83. PubMed ID: 26722392
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway.
Huang P; Yu C; Liu XQ; Ding YB; Wang YX; He JL
Int J Mol Med; 2011 Oct; 28(4):579-87. PubMed ID: 21687933
[TBL] [Abstract][Full Text] [Related]
3. Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway.
Bian Q; Liu P; Gu J; Song B
Int J Clin Exp Pathol; 2015; 8(10):12517-24. PubMed ID: 26722439
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Liu G; Kong W; Gao R; Su J
Mol Med Rep; 2018 Mar; 17(3):4327-4336. PubMed ID: 29363720
[TBL] [Abstract][Full Text] [Related]
5. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells.
Zhang Y; Xu X; He P
Mol Med Rep; 2011; 4(1):25-9. PubMed ID: 21461558
[TBL] [Abstract][Full Text] [Related]
6. Tubeimoside‑1 induces apoptosis in human glioma U251 cells by suppressing PI3K/Akt‑mediated signaling pathways.
Cao LJ; Xie HT; Chu ZX; Ma Y; Wang MM; Shi Z
Mol Med Rep; 2020 Aug; 22(2):1527-1535. PubMed ID: 32627020
[TBL] [Abstract][Full Text] [Related]
7. Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro.
Yang JB; Khan M; He YY; Yao M; Li YM; Gao HW; Ma TH
Acta Pharmacol Sin; 2016 Jul; 37(7):950-62. PubMed ID: 27292614
[TBL] [Abstract][Full Text] [Related]
8. Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca²⁺ and caspase-dependent signaling pathways.
Chen WJ; Yu C; Yang Z; He JL; Yin J; Liu HZ; Liu HT; Wang YX
Int J Oncol; 2012 Feb; 40(2):535-43. PubMed ID: 21971569
[TBL] [Abstract][Full Text] [Related]
9. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
Zhu X; Wang K; Zhang K; Zhu L; Zhou F
Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
[TBL] [Abstract][Full Text] [Related]
10. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
[TBL] [Abstract][Full Text] [Related]
11. Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells.
Xu Y; Ching YP; Zhou Y; Chiu JF; Chen F; He QY
J Proteomics; 2011 Dec; 75(2):491-501. PubMed ID: 21903181
[TBL] [Abstract][Full Text] [Related]
12. Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line.
Wang F; Ma R; Yu L
Cancer Chemother Pharmacol; 2006 Feb; 57(3):389-99. PubMed ID: 16172906
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
Su CC
Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
[TBL] [Abstract][Full Text] [Related]
14. Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression.
Peng Y; Zhong Y; Li G
BMB Rep; 2016 Sep; 49(9):502-7. PubMed ID: 27157541
[TBL] [Abstract][Full Text] [Related]
15. Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway.
Jia G; Wang Q; Wang R; Deng D; Xue L; Shao N; Zhang Y; Xia X; Zhi F; Yang Y
Onco Targets Ther; 2015; 8():303-11. PubMed ID: 25674005
[TBL] [Abstract][Full Text] [Related]
16. Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.
Ma R; Song G; You W; Yu L; Su W; Liao M; Zhang Y; Huang L; Zhang X; Yu T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):559-68. PubMed ID: 18030471
[TBL] [Abstract][Full Text] [Related]
17. Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway.
Jiang SL; Guan YD; Chen XS; Ge P; Wang XL; Lao YZ; Xiao SS; Zhang Y; Yang JM; Xu XJ; Cao DS; Cheng Y
Acta Pharmacol Sin; 2019 Jul; 40(7):919-928. PubMed ID: 30315250
[TBL] [Abstract][Full Text] [Related]
18. TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53/MDM2-dependent mechanism, a quantitative proteomics study.
Lin Y; Xie G; Xia J; Su D; Liu J; Jiang F; Xu Y
Biochim Biophys Acta; 2016 Feb; 1864(2):204-10. PubMed ID: 26549658
[TBL] [Abstract][Full Text] [Related]
19. Tubeimoside-1 exerts cytotoxicity in HeLa cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways.
Xu Y; Chiu JF; He QY; Chen F
J Proteome Res; 2009 Mar; 8(3):1585-93. PubMed ID: 19215086
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of tubeimoside-I on murine colorectal cancers through PKM2-dependent pyroptosis and immunomodulation.
Hu D; Cui L; Zhang S; He S; Zhuo Y; Li D; Zhang L; Wang Y; Yang L; Wang X
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4069-4087. PubMed ID: 38010398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
